IP Library › Granted Patent US 7,745,670
Granted Patent B2
US 7,745,670 · App. 12/343,750 · Granted Jun 29, 2010

Curcumin-Resveratrol hybrid molecule

Assignee: Codman & Shurtleff, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,745,670
App. No.
12/343,750
Granted
Jun 29, 2010
Kind
B2
Abstract

Novel molecules based upon hybridization of curcumin and hydroxystilbenes, such as resveratrol. It is believed that these novel molecules will have special application in treating Alzheimer's Disease.

Claims (3)

1. 1-hydroxyl 3,5-bis(4′-hydroxyl styryl)benzene.

2. 1,3-dihydroxyl 4,6-bis(4′-hydroxyl styryl)benzene.

3. 1-hydroxyl 3,5-bis(3′,4′-dihydroxyl styryl)benzene.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2013
From: CODMAN & SHURTLEFF, INC
To: DEPUY SPINE, LLC
Reel/Frame 031762/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2013
From: DEPUY SPINE, LLC
To: HAND INNOVATIONS LLC
Reel/Frame 031762/0134 →
CHANGE OF NAME Recorded Dec 11, 2013
From: HAND INNOVATIONS LLC
To: DEPUY SYNTHES PRODUCTS, LLC
Reel/Frame 031795/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2009
From: DIMAURO, THOMAS M.
To: CODMAN & SHURTLEFF, INC.
Reel/Frame 022389/0115 →
Continuity (3)
Continuation In Part 1214788100 · Jun 27, 2008
Provisional Application 6112291900 · Dec 16, 2008
Related Publication 20090326275A1 · Dec 31, 2009